Technologies

AAX Biotech is developing new technologies to improve antibodies for therapy, the fastest growing segment in pharmaceuticals for more than 20 years.

  • Seqitope is a high resolution, high throughput method for antibody epitope mapping
  • Opti-mAb is a new scFv-format with dramatically improved expression levels and reduced aggregation tendency